Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Developmental pharmacokinetics.
van den Anker JN, Schwab M, Kearns GL. van den Anker JN, et al. Handb Exp Pharmacol. 2011;205:51-75. doi: 10.1007/978-3-642-20195-0_2. Handb Exp Pharmacol. 2011. PMID: 21882105
Developmental pharmacology.
van den Anker JN. van den Anker JN. Dev Disabil Res Rev. 2010;16(3):233-8. doi: 10.1002/ddrr.122. Dev Disabil Res Rev. 2010. PMID: 20981761 Review.
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
Zhao W, Hill H, Le Guellec C, Neal T, Mahoney S, Paulus S, Castellan C, Kassai B, van den Anker JN, Kearns GL, Turner MA, Jacqz-Aigrain E; TINN Consortium. Zhao W, et al. Among authors: van den anker jn. Antimicrob Agents Chemother. 2014 Nov;58(11):6572-80. doi: 10.1128/AAC.03568-14. Epub 2014 Aug 25. Antimicrob Agents Chemother. 2014. PMID: 25155587 Free PMC article. Clinical Trial.
Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
Leroux S, Turner MA, Guellec CB, Hill H, van den Anker JN, Kearns GL, Jacqz-Aigrain E, Zhao W; TINN (Treat Infections in NeoNates) and GRiP (Global Research in Paediatrics) Consortiums. Leroux S, et al. Among authors: van den anker jn. Clin Pharmacokinet. 2015 Dec;54(12):1273-85. doi: 10.1007/s40262-015-0291-1. Clin Pharmacokinet. 2015. PMID: 26063050
Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D, Plavka R, Shinwell ES, Hallman M, Jarreau PH, Carnielli V, Van den Anker JN, Meisner C, Engel C, Schwab M, Halliday HL, Poets CF; NEUROSIS Trial Group. Bassler D, et al. Among authors: van den anker jn. N Engl J Med. 2015 Oct 15;373(16):1497-506. doi: 10.1056/NEJMoa1501917. N Engl J Med. 2015. PMID: 26465983 Free article. Clinical Trial.
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
Bassler D, Shinwell ES, Hallman M, Jarreau PH, Plavka R, Carnielli V, Meisner C, Engel C, Koch A, Kreutzer K, van den Anker JN, Schwab M, Halliday HL, Poets CF; Neonatal European Study of Inhaled Steroids Trial Group. Bassler D, et al. Among authors: van den anker jn. N Engl J Med. 2018 Jan 11;378(2):148-157. doi: 10.1056/NEJMoa1708831. N Engl J Med. 2018. PMID: 29320647 Free article. Clinical Trial.
361 results